Llanos-Cuentas A, Casapia M, Chuquiyauri R, et al. Antimalarial activity of single-dose DSM265, a novel Plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Lancet Infect Dis 2018; 18: 874–83—the open access license of this Article has been corrected to a Gold CC BY license. This correction has been made to the online version as of June 18, 2018, and will be made to the printed Article.
. 2018 Aug;18(8):829. doi: 10.1016/S1473-3099(18)30412-2
Corrections
© 2018 The Author. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC6060172 PMID: 29929782